Repetitive transcranial magnetic stimulation (rTMS) using different TMS instruments for major depressive disorder at a suburban tertiary clinic

Maria Cristina Davila (Awakenings KC Clinical Neuroscience Institute, KS;)
Brianna Ely (Awakenings KC Clinical Neuroscience Institute, KS;)
Ann M. Manzardo (Department of Psychiatry and Behavioral Sciences, University of Kansas Medical Center, KS, USA)

Mental Illness

ISSN: 2036-7465

Article publication date: 22 March 2019

487
This content is currently only available as a PDF

Abstract

Repetitive transcranial magnetic stimulation (rTMS) is a neurostimulatory technique used to modulate orbital frontal corticostriatal (OFC) activity and clinical symptomatology for psychiatric disorders involving OFC dysfunction. We examined the effectiveness of rTMS in the treatment of major depressive disorder in an applied clinical setting (Awakening KC CNI) to assess efficacy and optimize rTMS parameters within clinical practice. A retrospective review of medical records was carried out on patients with major depressive disorder undergoing rTMS therapy at Awakenings KC Clinical Neuroscience Institute (CNI), a suburban tertiary psychiatric clinic. A detailed de-identified data set of clinical outcomes was compiled. Patient Health Questionnaire 9 (PHQ-9) total score, clinical remission rate and week achieved were evaluated over 6 weeks of treatment to assess clinical response referencing two different rTMS instruments (MagVenture; NeuroStar). Our survey included 247 participants from males (N=98) and females (N=149) with average baseline PHQ-9 scores of 21.7±4, classified as severe depression. Clinically rated remission rates of 72% were achieved in 3.1±1.0 weeks and associated with prior history of psychiatric hospitalization, suicide attempts and substance use disorder. Average baseline PHQ-9 scores decreased significantly over time with proportionately greater remission rates achieved for patients treated using the MagVenture over NeuroStar instrument. rTMS in applied clinical practice is efficacious over a wide range of settings and patients. Clinical response was related to severity of depression symptoms (e.g., prior hospitalization; suicide attempts) validating efficacy in critically ill groups. Clinical response may be impacted by rTMS instrument, magnetic field parameters or individual factors.

Keywords

Citation

Davila, M.C., Ely, B. and Manzardo, A.M. (2019), "Repetitive transcranial magnetic stimulation (rTMS) using different TMS instruments for major depressive disorder at a suburban tertiary clinic", Mental Illness, Vol. 11 No. 1, pp. 1-8. https://doi.org/10.1108/mi.2019.7947

Publisher

:

Emerald Publishing Limited

Copyright © 2019 M.C. Davila et al.

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).


Corresponding author

Ann M. Manzardo, Department of Psychiatry & Behavioral Sciences, University of Kansas Medical Center, 3901 Rainbow Boulevard, Mail Stop 4015, Kansas City, Kansas 66160, KS, USA. Tel.: +1.913.5886473 - Fax: +1.913.5881305.

Related articles